Healthy volunteers needed to test new drug interactions
NCT ID NCT07550621
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how two common drugs, rifampin and itraconazole, change the levels of MDR-001 in the body. It involves 28 healthy Chinese adults who will take MDR-001 alone and then with one of the other drugs. The goal is to gather safety and drug-level data, not to treat any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS (HV) are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The First Hospital of Jilin University
Changchun, Jilin, 130021, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can pulsing light on the scalp boost brain performance?
- Can heavy water reveal how the liver makes fat?
- Which bridge exercise fires up your muscles most? a study investigates
- A new molecule enters human testing: can ZE66-0205 prove safe?
- Reading DNA clues: a blood test that could sniff out lung cancer
- Blood flow restriction may change how hamstrings use oxygen during exercise